KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Long-Term Debt Repayments (2017 - 2025)

LifeMD (LFMD) has disclosed Long-Term Debt Repayments for 12 consecutive years, with $16.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Long-Term Debt Repayments rose 127914.08% year-over-year to $16.7 million, compared with a TTM value of $16.7 million through Dec 2025, up 4991.76%, and an annual FY2025 reading of $18.7 million, up 5614.25% over the prior year.
  • Long-Term Debt Repayments was $16.7 million for Q3 2025 at LifeMD, up from $13020.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $16.7 million in Q3 2025 and bottomed at $13020.0 in Q3 2024.
  • Average Long-Term Debt Repayments over 4 years is $3.6 million, with a median of $515917.5 recorded in 2021.
  • The sharpest move saw Long-Term Debt Repayments crashed 98.02% in 2024, then surged 127914.08% in 2025.
  • Year by year, Long-Term Debt Repayments stood at $13.5 million in 2021, then tumbled by 99.27% to $98626.0 in 2023, then tumbled by 86.8% to $13020.0 in 2024, then soared by 127914.08% to $16.7 million in 2025.
  • Business Quant data shows Long-Term Debt Repayments for LFMD at $16.7 million in Q3 2025, $13020.0 in Q3 2024, and $102887.0 in Q2 2024.